key: cord-0049398-t4xdld3b authors: Wenham, Clare title: What is the future of UK leadership in global health security post Covid‐19? date: 2020-08-28 journal: nan DOI: 10.1111/newe.12201 sha: ced4005fb87f172b32e11a92c4ba4ae232667292 doc_id: 49398 cord_uid: t4xdld3b nan "the UK has been pivotal in developing capacity and governance for responding to infectious disease across the world" This ability of the UK to lead has been strengthened by its National Health Service (NHS). Recently, Dr Tedros Ghebreyesus has advocated universal health coverage as a strategy to deliver on global health security. 5 In this respect, the NHS, providing healthcare free at the point of access, is the envy of many in the world. This has been the UK government's 'trump card' in establishing its global health leadershipby providing an exemplar of what is possible if governments invest in access to healthcare. Through this, the UK has been able to export models of working, technical expertise and even human resources to other parts of the world, demonstrating the strength of its integrated health system, a key part of which is infection control. It has further strengthened by the UK's status as a major funder of global health activities. It is one of the only countries to have 0.7 per cent of its Gross Domestic Product (GDP) earmarked for overseas development assistance in legislation, 6 the majority of which is spent on health. The UK is the second largest donor to the Global Fund for HIV/AIDS, tuberculosis and malaria 7 and it has committed significant funds to the World Bank's International Development Association replenishment. These structural elements are then rapidly deployed by the UK in an outbreak response. For example, during the ebola outbreak in West Africa: This is at odds with the UK's track record in disease control. In 2019, the UK came second globally in the Global Health Security Index's assessment of capacity to respond to outbreaks. 14 Yet, such measurements of policy tools and response mechanisms fail to assess political prioritisation or financial neglect. Yes, the UK does have an exceptional disease response system on paper, but politics has left it bereft of funding and implementability. "the UK does have an exceptional disease response system on paper, but politics has left it bereft of funding and implementability" It is strange that the UKa global health leaderdid not follow global health advice, with severe consequences. While the government claim their decisions have followed the science, closer examination reveals that our outcomes have been determined by bad politics, rather than bad evidence. The failure of our Covid-19 strategy exposes a pattern of complacency lasting years. The last major outbreaks to affect the UK were bovine spongiform encephalopathy (BSE) in the early 1990s and the foot and mouth outbreak in 2001. Even when Pauline Cafferkey became the UK's first case of Ebola in 2016, rigorous infection control protocol meant this would never pose a major issue to UK security. It appears that these near misses gave government a false sense of security. That is, despite pandemics featuring in name at the top of the UK's National Risk Register, 15 the UK government became complacent to the real risk of pandemics, and subsequently failed to ensure the practical readiness of the established protocols. In the case of Covid-19, this was amplified by competing political priorities, such as continued austerity implemented by successive UK governments and, of course, Brexit. Exercise Cygnusa real world simulation of a British disease outbreak -highlighted gaps in the UK's pandemic response. Yet, the continued underfunding of the NHS has meant that while a need for surge capacity was identified -in personal protective equipment (PPE), ventilators and intensive care unit bedsthe extra resource was not purchased. 16 They fell victim to the same programme of 'efficiency cuts' that has seen NHS funding and public health services rolled back. 17 The short sightedness of the latter is now particularly clear. The UK government's reduction in investment in public health prevention, such as in smoking, alcohol and obesity, 18 has not only led to entirely preventable chronic conditions, but also these conditions are now proving to be significant risk factors for coronavirus. The political prioritisation of Brexit has further challenged domestic health security. It appears that: • training for keyworkers to manage a pandemic was stalled for contingency plans around no-deal Brexit • the UK missed opportunities for European Union-level purchasing of PPE 19 • parliamentary enquiries into preparedness for infectious disease were delayed, and eventually halted due to the 2019 general election. 20 It's clear that political goals trumped those of pandemic preparedness. This gap between the UK's role in promoting internationalist visions of infectious disease control globally, and its inability to control a pandemic at home, is stark. This makes for an interesting future in global health security, and brings into question the role of UK soft-power and leadership. "This gap between the UK's role in promoting internationalist visions of infectious disease control globally, and its inability to control a pandemic at home, is stark" In an effort to try to maintain its position, the UK government has taken steps to ensure its future leadership role. It has committed to: • ensuring funding to the WHO (for which it is now the world's largest state funder with the withdrawal of the United States) • the hosting of a global vaccine summit in June 21 • renewing its commitment to Gavi This is importantthe global health landscape is being rapidly transformed, not only by the response to Covid-19, but also through the apparent shifting balance of power away from the United States amid the pandemic. The Trump administration appears committed to blowing up all internationalist activity, challenging the WHO to reform within 30 days (a process the WHO has been undertaking for a decade without success due to governments being unwilling to give the organisation more money or more power). 23, 24 Simultaneously, China is entering multilateral activities with more gusto than previously, and for how long and in what Statement on Global Vaccine Summit', GOV.UK website Gavi welcomes UK funding pledge', Gavi press release What's the World Health Organization For? Chatham House World Health Organization reform: lessons learned from the ebola epidemic capacity remains to be seen. This could be the perfect opportunity for the UK to exert dominance in this space.There is every chance that this will be an agenda worth leading on. Not only is there likely to be increased political importance placed on health security in a post-Covid-19 era, but also Covid-19 is tied up in environmental disaster and climate change. These could cause future outbreaks, tying global health and global climate policy together. In January 2019, the World Economic Forum noted this, alongside new analysis showing acceleration in the number of 'major disease' outbreaks being faced by the world. 25 Moreover, global health security could be the perfect domain for the UK to show its commitment to a 'Global Britain'. Given the reputational impact of Brexit, such opportunities are important for our international reputation.But, with more than 50,000 deaths in the UK due to coronavirus and 250,000 cases, the UK is not demonstrating the necessary normative leadership in health at home. Mixed messaging from the government to "stay alert" to end lockdown will likely end in a second wave of the epidemic appearing. Once again, the UK government will be forced to make decisions between economic and health security.Given its departure from global solidarity approaches to the Covid response, leading to system-wide failures, why would any international government seek the UK's advice again?Clare Wenham is assistant professor of global health policy at the London School of Economics and Political Science (LSE). She is director of the MSc in global health policy and sits on the steering committee of the LSE Global Health Initiative. Before entering academia, Clare worked in public health policy roles.